Shuttle Pharmaceuticals Holdings, Inc.

SHPH

Shuttle Pharmaceuticals Holdings, Inc.

SHPH

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2023-12-13Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2024-03-31Institutional Shares Owned:38,910Shares Outstanding:83,030Institutional Ownership Pct.:46.86%

Earnings Market Reaction:

Filing Date:2026-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Cash And Cash Equivalents At Carrying Value	1	0	2	5	5	2	0	1	1	3	4	5
Prepaid Expense And Other Assets Current	1	0	1	0	0	0	0	0	0	0	0	0
Assets Current
Assets Current	2	1	3	5	5	2	0	2	4	6	7	8
Marketable Securities Current	-	-	-	-	-	-	-	2	3	3	3	3
Interest Receivable Current	-	-	-	-	-	-	0	0	0	0	0	0
Other Assets Current	-	-	-	-	-	-	-	-	0	-	0	0
Deferred Costs Current	-	-	-	-	-	-	0	-	-	-	-	-
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	9	10	-	-	-	-	-	-	-	-	-	-
Deferred Costs	-	0	0	0	0	-	-	-	-	-	-	-
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Assets	12	10	4	6	5	3	1	3	5	6	7	9
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current	2	1	1	1	1	1	-	-	-	-	-	-
Interest Payable Current	-	-	-	-	-	0	-	0	0	-	-	-
Liabilities Current
Convertible Notes Payable Current	-	-	-	-	-	-	-	1	-	1	-	-
Liabilities Current	8	8	2	2	2	2	2	1	1	1	1	0
Derivative Liabilities Current	-	-	-	-	-	-	-	0	0	-	-	-
Notes Payable Current	-	-	-	-	-	0	-	-	-	-	-	-
Asset Acquisition Contingent Consideration Liabili…	2	2	-	-	-	-	-	-	-	-	-	-
Business Combination Contingent Consideration Liab…	4	4	-	-	-	-	-	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Convertible Long Term Notes Payable	-	-	-	-	-	-	-	-	-	0	0	0
Derivative Liabilities	-	-	-	-	-	-	-	-	-	0	-	-
Derivative Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	1	1
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	8	8	2	2	2	2	2	2	2	2	2	2
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	52	49	45	45	41	35	32	30	30	29	19	19
Stockholders Equity	3	2	1	4	3	1	-1	1	3	4	6	7
Retained Earnings Accumulated Deficit	-48	-46	-44	-41	-38	-35	-33	-29	-27	-25	-14	-12
Liabilities And Stockholders Equity	12	10	4	6	5	3	1	3	5	6	7	9
Accumulated Depreciation Depletion And Amortizatio…	-	-	-	-	-	-	-	-	-	0	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Liquidation Preference	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	20	20	1	1	20	20	20	20	20	20	20	20
Preferred Stock Shares Issued	-	-	-	-	-	-	-	0	-	-	-	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	6	2	1	1	0	0	0	0	0	0	0	0
Shares Outstanding	6	2	1	1	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-31.83%	-46.25%	-42.94%	-	-	-	-	-	-	-	-	-
2025	-35.19%	-49.19%	-42.67%	-4.80%	26.55%	-16.10%	-24.24%	-21.65%	-12.55%	51.69%	-14.29%	-49.04%
2024	16.25%	-2.75%	-7.50%	-44.30%	-47.26%	-63.25%	-32.61%	-15.95%	-32.16%	-29.83%	-57.67%	-64.00%
2023	-12.61%	-13.45%	-30.50%	-20.11%	-36.67%	-42.53%	-0.40%	14.94%	-20.32%	-9.51%	-7.52%	2.88%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	0.30	0.06	1.66	3.07	2.78	1.44	0.22	1.79	2.96	5.37	8.63	17.10
Quick Ratio	0.13	0.04	1.07	2.85	2.53	1.25	0.16	1.69	2.87	5.26	8.42	16.94
Working Capital	-5.84M	-7.46M	1.30M	3.50M	3.18M	677.15K	-1.30M	1.10M	2.92M	4.55M	6.19M	7.95M
Leverage & Debt
Debt to Equity	2.53	3.65	1.54	0.53	0.62	2.53	-1.51	2.51	0.72	0.47	0.31	0.27
Interest Coverage TTM	-3,353.04	-1,365.04	-713.49	-699.98	-657.53	-885.43	-3,370.08	-	-2,215.01	-863.35	-135.93	-91.00
Debt Ratio	0.72	0.78	0.61	0.34	0.38	0.72	2.95	0.72	0.42	0.32	0.24	0.22
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-2.15	-7.16	-4.79	-10.78	-26.04	-79.18	-96.70	-85.46	-88.51	-88.31	-135.56	-139.12
Free Cash Flow Per Share TTM	-1.86	-5.79	-5.01	-9.39	-21.43	-63.82	-59.99	-62.41	-66.26	-75.02	-65.66	-79.35
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	3.39%	28.18%	16.53%	68.74%	42.43%	38.71%	-13.99%	-27.37%	-	-	-	-
EPS Growth (1Y)	-91.74%	-91.02%	-95.04%	-87.38%	-70.58%	-9.81%	-28.67%	-38.57%	-	-	-	-
Valuation Metrics
P/E TTM	-3.16	-2.52	-7.41	-3.49	-3.73	-2.70	-3.44	-9.36	-9.17	-10.30	-9.00	-16.53
P/B TTM	10.21	13.08	56.88	11.76	11.90	34.77	-24.02	84.04	24.41	16.75	17.14	23.61
Market Cap	34.16M	29.48M	79.29M	42.40M	39.09M	24.65M	31.59M	67.36M	67.42M	67.93M	96.13M	163.78M
Enterprise Value	33.07M	29.15M	77.20M	37.58M	34.58M	22.92M	31.43M	67.49M	66.02M	66.09M	92.38M	158.45M
Calculated Values
Free Cash Flow TTM	-9.37M	-9.48M	-11.20M	-10.57M	-8.62M	-7.33M	-5.70M	-5.25M	-5.50M	-5.60M	-5.17M	-5.65M
Net Debt	-1.09M	-334.01K	-2.09M	-4.82M	-4.51M	-1.73M	-156.66K	130.64K	-1.40M	-1.85M	-3.75M	-5.32M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-12-13Sale

Owner: Brown, Milton

Title: -

Shares: 2,921

Price/Share: $0.46

Value: $1,343.66

Shares Owned: 1,094,610

Relationship: Director

Ownership: Direct

2023-12-13Sale

Owner: Jacobs, Bette

Title: -

Shares: 4,157

Price/Share: $0.46

Value: $1,912.22

Shares Owned: 27,064

Relationship: Director

Ownership: Direct

2022-12-29Sale

Owner: Vander, Hoek Michael

Title: Chief Financial Officer

Shares: 2,243

Price/Share: $1.61

Value: $3,611.23

Shares Owned: 3,852

Relationship: Officer

Ownership: Direct

2022-12-29Sale

Owner: Dritschilo, Anatoly

Title: CEO and Chairman

Shares: 8,372

Price/Share: $1.61

Value: $13,478.92

Shares Owned: 1,085,200

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2022-12-29Sale

Owner: Richards, Steven M

Title: -

Shares: 995

Price/Share: $1.61

Value: $1,601.95

Shares Owned: 1,707

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-12-13	Brown, Milton	Director	-	Direct	Sale	2,921	0.46	$1,343.66	1,094,610	4
2023-12-13	Jacobs, Bette	Director	-	Direct	Sale	4,157	0.46	$1,912.22	27,064	4
2022-12-29	Vander, Hoek Michael	Officer	Chief Financial Officer	Direct	Sale	2,243	1.61	$3,611.23	3,852	4
2022-12-29	Dritschilo, Anatoly	Director,Officer,TenPercentOwner	CEO and Chairman	Direct	Sale	8,372	1.61	$13,478.92	1,085,200	4
2022-12-29	Richards, Steven M	Director	-	Direct	Sale	995	1.61	$1,601.95	1,707	4
2022-12-29	Adkins, William	Other	-	Direct	Sale	995	1.61	$1,601.95	184,071	4
2022-12-29	Jacobs, Bette	Director	-	Direct	Sale	4,366	1.61	$7,029.26	31,221	4
2022-12-29	Brown, Milton	Director	-	Direct	Sale	995	1.61	$1,601.95	1,072,531	4
2022-12-29	Rich, Tyvin	Officer	Chief Medical Officer	Direct	Sale	1,414	1.61	$2,276.54	2,429	4
2022-12-29	Dritschilo, Peter	Officer	President and COO	Direct	Sale	3,820	1.61	$6,150.20	6,560	4
2022-12-29	Jung, Mira	Officer	Chief Scientific Officer	Direct	Sale	328	1.61	$528.08	1,071,388	4
2022-12-29	Senanayake, Chris	Director	-	Direct	Sale	1,626	1.61	$2,617.86	2,791	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2024-03-31

46.86%

Inst. Shares: 38,910

Shares Outstanding: 83,030

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2024-03-31	38,910	83,030	46.86%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) — SEC Financial Statements & Analysis

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is a pharmaceutical preparations company, incorporated in DE. Shuttle Pharmaceuticals Holdings, Inc. trades on Nasdaq as: SHPH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Shuttle Pharmaceuticals Holdings, Inc. reported a Debt-to-Equity ratio of 2.53x, a Price-to-Book (P/B) ratio of 10.21x (TTM), at a market cap of $34.16M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 2.53x
P/B TTM: 10.21x
Market Cap: $34.16M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Shuttle Pharmaceuticals Holdings, Inc. in?

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) operates in the Pharmaceutical Preparations industry.

What is SHPH's market cap?

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has a market capitalization of $34.16M as of 2026-03-31.

What exchange does SHPH trade on?

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) trades on the Nasdaq.

Where is Shuttle Pharmaceuticals Holdings, Inc. incorporated?

Shuttle Pharmaceuticals Holdings, Inc. is incorporated in DE.